Internal Medicine, Hematology & Oncology · Norwich, CT
NPI
1659356640
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
330 Washington St, Ste 220 Eastern Ct Hematology & Oncology
Norwich, CT, 06360
Phone (860) 886-8362
Groups this clinician bills Medicare through
Medicare paid, 2024
$87K
1,368 services
Medicare patients, 2024
376
Average age 75
Drug cost, 2024
$2.6M
1,797 prescriptions
Company payments, 2023
$17.98
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anca Bulgaru was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 383 times for 189 patients. In total Anca Bulgaru billed 1,368 services in 19 codes, and Medicare paid $87K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-07-22.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 383 | 189 | $14.01 | $5,368 |
| 99214 Office E&M - Established | Office | 371 | 191 | $74.22 | $28K |
| 99215 Office E&M - Established | Office | 199 | 92 | $117.13 | $23K |
| 99213 Office E&M - Established | Office | 108 | 80 | $47.44 | $5,123 |
| 99232 Hospital E&M - Subsequent | Facility | 60 | 47 | $65.46 | $3,928 |
| 99231 Hospital E&M - Subsequent | Facility | 50 | 40 | $42.49 | $2,124 |
| 99233 Hospital E&M - Subsequent | Facility | 47 | 31 | $100.17 | $4,708 |
| 99222 Hospital E&M - Initial | Facility | 30 | 30 | $108.79 | $3,264 |
| 99205 Office E&M - New | Office | 27 | 27 | $155.92 | $4,210 |
| 99223 Hospital E&M - Initial | Facility | 26 | 26 | $149.01 | $3,874 |
| 99221 Hospital E&M - Initial | Facility | 20 | 20 | $60.55 | $1,211 |
| 99212 Office E&M - Established | Office | 18 | 16 | $23.69 | $427 |
| 99204 Office E&M - New | Office | 11 | 11 | $99.83 | $1,098 |
By year: 2022 $65K for 928 services; 2023 $68K for 916 services; 2024 $87K for 1,368 services.
Medicare prescription drug claims, 2024
In 2024, the drug Anca Bulgaru prescribed most often to Medicare patients was Anastrozole, with 411 prescriptions and refills. In total Anca Bulgaru wrote 1,797 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 411 | 1,040 | 117 | $8,667 |
| Tamoxifen Citrate Generic | 138 | 372 | 42 | $3,560 |
| Eliquis Apixaban | 131 | 231 | 33 | $129K |
| Gabapentin Generic | 98 | 220 | 32 | $1,367 |
| Ibrance Palbociclib | 65 | 65 | Under 11 | $934K |
| Xarelto Rivaroxaban | 61 | 120 | 14 | $65K |
| Exemestane Generic | 52 | 86 | Under 11 | $6,110 |
| Letrozole Generic | 48 | 134 | 17 | $1,510 |
| Escitalopram Oxalate Generic | 40 | 90 | 14 | $394 |
| Potassium Chloride Generic | 35 | 92 | 14 | $608 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 27 | 27 | Under 11 | $294 |
| Lorazepam Generic | 26 | 26 | 13 | $24.62 |
| Oxycodone Hcl Generic | 26 | 26 | 15 | $302 |
| Veozah Fezolinetant | 25 | 25 | Under 11 | $14K |
| Hydrochlorothiazide Generic | 25 | 35 | Under 11 | $106 |
Brand drugs: 399 claims; generic drugs: 1,398 claims; opioid claims: 104.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Anca Bulgaru $17.98 ($17.98 in general payments such as food, travel and fees) from 1 company. The largest payer was Janssen Biotech, Inc. with $17.98.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 1 | $17.98 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.